College students across the United States are suffering from anxiety at staggering rates. More and more young adults are having difficulty keeping up with their studies while dealing with their own internal struggles. Anxiety disorder exists on a spectrum with some individuals suffering from such severe cases that it seems like everything becomes nearly impossible …
Ketamine is a drug that is completely unique, and when it comes to treating depression, the results have been so good, it’s shocked many in psychiatry. “This is a game-changer,” Dr. John Krystal, chief psychiatrist at Yale Medicine, told Medical Xpress. “When you take ketamine, it triggers reactions in your cortex that enable brain connections …
Abstract Numerous placebo-controlled studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to induce rapid (within hours), transient antidepressant effects when administered intravenously (IV) at subanesthetic doses (0.5 mg/kg over 40 min). However, the optimal antidepressant dose remains unknown. We aimed to compare to active placebo the rapid acting antidepressant properties of a …
Illustration by Kotryna Zukauskaite Geuris “Jerry” Rivas, a native of New York, was diagnosed with severe obsessive-compulsive disorder when he was 15. Obsessions with organizing and reorganizing the belongings in his bedroom — posters, comic books, videos — took over most of his life. Forced by germ obsessions to compulsively wash and rewash his hands, …
One of the most crippling aspects of anxiety is how isolating it can be. The feelings of fear, worry, and panic, can attack even the most self-assured person and make them feel desperately alone. The irony is that despite these feelings of isolation, anxiety is the most common mental illness in America today. More than …
Anxiety is a typical response when you’re experiencing stressful events throughout your life. For example, if you’re experiencing financial problems, starting a new family, or changing jobs, you may experience some modicum of anxiety. However, if the anxiety symptoms persist or exasperate beyond their trigger and interfere with your everyday life, then you may be …
Key Findings Approximately 6-7% of full-time U.S. workers experienced major depression (MDD) within the past year. The total economic burden of MDD is now estimated to be $210.5 billion per year. For every dollar spent on MDD direct costs in 2010, an additional $1.90 was spent on MDD-related indirect costs. An important study reveals just …
At last count, about 12% of Americans took antidepressants. Global revenue for antidepressants was about $14.5 billion in 2014 and is projected to grow to nearly $17 billion over the next three years. Clinical depression affects 6.7% of U.S. adults, or about 16 million people, and a growing number of children and teenagers too. It’s …
On March 5, 2019 the Food and Drug Administration (FDA) approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made waves for its surprising antidepressant effect. Interestingly, studies from Yale research labs showed that the drug ketamine, which was widely used as …
If you are one of the 40 million people who suffer from anxiety, then you know how terrifying it can feel. Perhaps worst of all, the horrifying effects of anxiety can come from out of nowhere. One second you are enjoying an evening with friends and the next you feel like you are fighting for …
Bespoke Treatment focuses on non-medication treatments that work. We are the first boutique center in Southern California to specialize in personalized TMS therapy, Ketamine treatment, and psychiatry.
